Meloxicam Lph (Meloxicam)

Meloxicam selectively blocks the cyclooxygenase‑2 (COX‑2) enzyme, which is responsible for producing prostaglandins that mediate inflammation, pain, and fever. By inhibiting COX‑2, meloxicam lowers prostaglandin levels, thereby decreasing inflammation and providing analgesic effects while largely preserving COX‑1 activity.

The exact dose of Meloxicam Lph is determined by the prescribing clinician based on the patient’s condition, severity, age, renal and hepatic function, and other individual factors. Healthcare professionals tailor the regimen to achieve optimal therapeutic benefit while minimizing risk.

The safety of meloxicam in pregnancy and lactation has not been definitively established. It is generally advised to avoid use unless the potential benefit justifies the possible risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss alternatives with their healthcare provider.

To place an order, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements), and necessary import documentation.

Meloxicam offers relatively selective COX‑2 inhibition compared with non‑selective NSAIDs such as ibuprofen or naproxen, which may result in a lower incidence of gastrointestinal irritation. However, it still carries cardiovascular and renal risks similar to other NSAIDs, and the choice of agent should be individualized based on patient risk factors.

Meloxicam Lph should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in their original packaging, protect them from moisture, heat, and direct sunlight to maintain potency throughout the shelf life.

Meloxicam Lph is supplied as oral tablets that are taken by mouth with or without food, as directed by a healthcare professional. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious adverse events include gastrointestinal ulceration or bleeding, cardiovascular complications such as heart attack or stroke, severe skin reactions (e.g., Stevens‑Johnson syndrome), hepatic injury, and acute renal failure. Patients should seek immediate medical attention if they experience symptoms like severe abdominal pain, chest pain, sudden swelling, or skin rash.

Meloxicam Lph is contraindicated in individuals with known hypersensitivity to meloxicam or other NSAIDs, those with active gastrointestinal bleeding or ulcer disease, severe heart failure, and patients who have had a recent coronary artery bypass graft. It should also be avoided in patients with significant renal or hepatic impairment unless closely monitored.